Navigation Links
Mylan Announces Appointment of David A. Lillback as Senior Vice President and Global Head of Human Resources
Date:10/1/2007

PITTSBURGH, Pa., Oct. 1 /PRNewswire-FirstCall/ -- Mylan Laboratories Inc. (NYSE: MYL) today announced the appointment of David A. Lillback as Senior Vice President and Global Head of Human Resources (HR), effective October 22, 2007. Mr. Lillback brings to Mylan more than 25 years of HR experience. He joins from Sanofi-Aventis where he served as Vice President of Human Resources, U.S., with responsibility for HR leadership for more than 16,000 employees. Prior to joining Sanofi-Aventis, Mr. Lillback held executive HR positions with LaRoche Industries and Kaiser Chemicals.

Mr. Lillback has extensive experience in establishing global HR operations, processes and policies; creating and implementing effective HR business strategies for successful and sustainable growth; and implementing improved benefit programs aligned with pharmaceutical industry trends. He also has demonstrated expertise in the recruitment and training of large sales teams and implementing HR information systems to ensure efficient management of talent, performance and compensation.

Mylan Vice Chairman and CEO Robert J. Coury commented: "As I've stated many times, we are clearly focused on building the management team at Mylan with the best and the brightest talent, and I am therefore pleased to welcome David to the Mylan family. With Mylan's significant global expansion, it becomes even more critical that we have in place the tools to identify, grow and develop talent around the world. David will ensure that our human resources activities are closely aligned with the fast-evolving needs of our business and that Mylan is the first choice for high potential candidates in the pharmaceutical sector. David will also ensure that we continue to provide the highest level of HR services and support for our existing employees around the world. Mylan's employees have always been our greatest asset and ensuring that they have the resources they need remains one of our greatest priorities."

Mr. Lillback earned an MBA and a bachelor's of science degree from Lake Erie College in Painesville, Ohio. He also has completed the International Executive Program at INSEAD business school in France.

Mylan Laboratories Inc. is a leading pharmaceutical company with three principal subsidiaries, Mylan Pharmaceuticals Inc., Mylan Technologies Inc. and UDL Laboratories Inc., and a controlling interest in Matrix Laboratories Limited, India. Mylan develops, licenses, manufactures, markets and distributes an extensive line of generic and proprietary products. For more information about Mylan, please visit http://www.mylan.com.


'/>"/>
SOURCE Mylan Laboratories Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Mylan Wins Its Amlodipine Case With Pfizer
2. Mylan Announces Tentative FDA Approval for Its ANDA
3. Mylan Announces Final FDA Approval for Fluoxetine Capsules
4. PM announces a new health care order for India
5. Ramdoss Announces Introduction of RCH-II
6. Britain Announces Third Transfusion Related Mad Cow Case
7. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
8. Tibet Announces the Dalai Lama’s Tour of South Americ
9. NHS announces further Cost cutting Measures
10. Indian PM Announces Of Setting Up India Study Center At Tashkent
11. PowderMed Announces Needle-Less Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... ... , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s ... design of the shoulder pad. The shoulder pad provides optimal support and full ... while using cold therapy. By utilizing ice and water that is circulated from an ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health ... interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), an ... education, today announce a new strategic alliance. , As CPEN’s strategic partner, ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, ... formed by Walgreens and pharmacy benefit manager Prime Therapeutics ... new brand, which included the unveiling of new signage ... , as well as at a few other company-owned ... new brand to patients, some of whom will begin ...
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion ... notable awards. Ranked as number one in the South Florida ... time in Inc. 5000 yearly list, the national specialty pharmacy ... Armando Bardisa will soon be honored by SFBJ ... Set to receive his award in ...
(Date:9/22/2017)... 2017  As the latest Obamacare repeal effort moves ... (R-LA) and Lindsey Graham (R-SC) medical ... device industry is in an odd place.  The industry ... excise tax on medical device sales passed along with ... patients, increased visits and hospital customers with the funding ...
Breaking Medicine Technology: